Chromosome 18p11
-
Upload
clarissasvezna -
Category
Documents
-
view
23 -
download
2
description
Transcript of Chromosome 18p11
Indian J Psychiatry. 2013 Oct-Dec; 55(4): 371–375.
doi: 10.4103/0019-5545.120567
PMCID: PMC3890926
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar
affective disorder
Mutahar Andrabi, Arshad Hussain, Fouzia Rashid, Sheikh Ozair Nissar, Idrees Ayoub Shah, Yasir Hasan Rather,
Waseem Hassan Ahangar, and Nazir Ahmad Dar
Department of Biochemistry, University of Kashmir, Jammu and Kashmir, India
Department of Psychiatry, Government Medical College, Srinagar, Jammu and Kashmir, India
Ram Manohar Lohia Hospital, New Delhi, India
Address for correspondence: Dr. Nazir Ahmad Dar, Department of Biochemistry, University of Kashmir, Hazratbal, Srinagar - 190 006,
Jammu and Kashmir, India. E-mail: [email protected]
Copyright : © Indian Journal of Psychiatry
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Aim:
The aim of our study was to investigate whether the tandem repeat polymorphism in D18S452
microsatellite marker at locus 18p11.2 is a risk factor of bipolar affective disorder (BPAD) in Kashmiri
population.
Materials and Methods:
The repeat polymorphism in D18S452 was evaluated by polymerase chain reaction (PCR) analysis of
in 74 diagnosed BPAD patients and 74 controls subjects.
Results:
Tandem repeat (300 bp*) allele frequency was found to be 1.35% in controls and 8.108% in cases. The
tandem repeat (250 bp*) allele frequency was found to be in 91.89% in cases and 98.65% in controls.
The 252 bp/252 bp genotype was found to be present in 89.18% of cases and 98.64% of controls, the
300 bp/300 bp genotype in 5.40% of cases and 1.35% of controls and the 252 bp/300 bp variant in
5.40% of cases and none among the controls. Although the proportion of patients homozygous for
tandem repeat (300 bp/300 bp) was higher in cases than in controls, the difference was not
statistically significant when 252 bp/252 bp genotype was taken as reference (odds ratio
[OR]=4.4242; 95% confidence interval [CI] 0.4822-40.5924); P=0.1529). However, when the
frequency of heterozygous genotype (252 bp/300 bp) was compared with 252 bp/252 bp statistical
significance was observed (OR=8.0603; 95% CI 1.1112-58.4646; P=0.0383).
Conclusion:
This is the first study reporting a significant association between D18S452 maker with tandem repeat
polymorphism in heterozygous condition (252 bp/300 bp) and the development of BPAD in Kashmiri
population.
1 2
1
1
2
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
1 of 13 1/27/2014 5:56 PM
Keywords: Allele frequency, bipolar disorder, genetic locus, linkage study, tandem repeats
INTRODUCTION
Bipolar affective disorder (BPAD) is a major psychiatric problem with multifactorial etiology affecting
approximately 1% of population[1] and with all other bipolar spectrum disorders the prevalence will
be as high as 5%.[2] Bipolar disorder is the sixth leading cause of medical disability world-wide
among people 15-44 years of age and the estimated disability-adjusted life years of bipolar disorder
outrank all cancers and primary neurologic disorders.[3] It is equally prevalent in males and
females.[1] Family[4], twin[5] and adoption studies[6] have established that there is a multiple
genetic contribution to bipolar disorder and regarding the mechanism of transmission it is thought to
be consistent with the epistatic action of several genes with modest individual effect sizes.[7,8,9]
Although the limits of phenotypic expression are not known, the family studies suggest that bipolar I,
bipolar II recurrent major (unipolar) depression and schizoaffective disorder are part of a bipolar
spectrum.[4]
Since most psychiatric disorders show a complex mode of inheritance and transmission, the BPAD is
no more an exception. Without identifying the genes involved, the mechanism that underlies the
pathophysiology of bipolar disorder cannot be elucidated and therefore it is not possible to think of
any relief and treatment to victims of the disorder. In the direction of identifying causative genetic
markers, various linkage studies on large pedigree cohorts have led to reproducible identification of
several susceptibility loci. These include regions on chromosomes 4q, 12q, 13q, 18, 21q and
22q.[10,11,12,13,14,15,16,17,18] Various types of studies have identified chromosome 18p as a highly
potential and susceptible locus, which carry a few candidate genes for affective mood disorder.
[9,19,20,21,22,23,24,25,26] To investigate this region, further studies like case-control for a marker
D18S452 (locus 18p11.2) association with BPAD is warranted. Microsatellite marker D18S452
contains 26 dinucleotide repeats (cytosine-adenine (CA)) (http://genome.ucsc.edu/cgi-bin
/hgTracks?org=human). Though, the incidence of BPAD in Kashmir is significant yet there has been
no genetic study from Kashmir until date and the existence of any genetic predisposition in this
population remains totally untouched and unexplored. The molecular and epidemiological studies
remain open for research and seem to be promising in addressing the various queries of BPAD
etiology in this area. Therefore, the current work was undertaken to determine the structure of the
marker and evaluation of any association between the chromosomal susceptibility locus and BPAD.
MATERIALS AND METHODS
Study subjects
The BPAD seems very frequent and a serious health problem in Kashmir Valley. All people who suffer
from such ailments report to the Psychiatric Disease Hospital at Srinagar, Kashmir for diagnosis and
treatments. Patients were diagnosed with the disorder by psychiatrists who used diagnostics and
statistical manual IV based instrument called Mini-International Neuropsychiatric interview at the
hospital Srinagar. Those confirmed to have BPAD without having any comorbid condition such as
thyroid disorder, migraine, panic disorder and/or eating disorder were enrolled as cases. All the
diagnosed patients were included irrespective of any grade (whether or not on medication), age or
gender. Controls were recruited from the general medicine wards of Shri Maharaja Hari Singh
Hospital, Srinagar following the referral pattern of sex and age matched patients. None of the controls
had a personal or family history of any psychiatric disorder which was confirmed by a consultant
psychiatrist. The study was approved by the Departmental Research Committee of the Department of
Biochemistry University of Kashmir Srinagar and Board of Research Studies, University of Kashmir. A
total of 148 subjects were taken in this study out of which 74 were cases and rests 74 were controls.
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
2 of 13 1/27/2014 5:56 PM
After the detailed explanation of the study, all the subjects provided written informed consent.
Sample collection and deoxyribonucleic acid extraction
Around (3 ml) peripheral blood was collected from each subject in sterilized plastic vials containing
ethylenediaminetetraacetic acid (0.5M; pH-8.0) and stored at −20°C for further analysis. DNA was
isolated by a standard phenol-chloroform extraction method.[27] The quality of the genomic DNA
was examined by gel electrophoresis using 0.8% agarose gel. The quantity of the DNA was estimated
by making appropriate dilutions to determine the optical density at 260 nm and 280 nm by double
beam spectrophotometer (spectron 2206) and the concentration was determined using equation:
DNA (μg/ml) = A × 50 × dilution factor
The ratio of A /A was calculated and the DNA samples for which the ratio was 1.7-1.9 were
considered for the future use.
Genotyping
Polymerase chain reaction (PCR) was performed in total volume of 25 μl. The PCR reactions mixture
composed of 50-150 ng genomic DNA; 0.2 mM dNTPs; 0.4 pmoles/μl of each primer; 1.5 U of Taq
polymerase in 1 × PCR buffer and 200 nM each of the forward primer: 5′-TGG GGC ATA CAT AGT
GCA AA-3′ and reverse primer: 5′-AGG CCT TTT GCT AGT TGG GT-3′. PCR cycling parameters were
a 4 min denaturation cycle at 94°C and 34 cycles of the following: 94°C for 45 s 59.2°C for 30 s and
72°C for 45 s and a final extension at 72°C for 5 min. The amplified products were visualized on a 3%
agarose gel using ethidium bromide.
Statistical analysis
The χ test was used for the comparison of the allele and genotype frequency between the cases and
controls. The distribution of the genotype frequencies in both groups did not deviate from the Hardy-
Weinberg equilibrium. The odds ratio (OR) were calculated as estimates of relative risk for disease
and 95% confidence intervals (CIs) were calculated for all observed allele frequencies. P < 0.05 was
considered as statistically significant. The SPSS statistical software package (version 11.5 SPSS
Chicago IL) was used for the statistical analysis.
RESULTS
Genotypic and allelic frequencies
In the present study, 74 BPAD cases and 74 matched controls belonging to the Kashmir division were
analyzed for D18S452 polymorphism. We found six types of alleles corresponding to base pair size:
200 bp; between 200 and 252 bp; 252 bp; between 252 and 300 bp; 300 bp; between 300 and 350
bp. On analyzing the allelic frequency two main groups turned out – rare and frequent genotype with
respect to the locus. Only two subjects (one from each case [1.35%] and control group [1.35%]) had
allelotype corresponding to 200 bp. There was just one case representation from each 200 bp to 250
bp; between 252 bp and 300 bp and 300-350 bp alleotypes. A single subject had from controls had
300 bp allelotype. 63 patients (87.16%) and 72 controls (97.297%) had allelotype corresponding to
252 bp. Seven patients (7.43%) had allelotype corresponding to 300 bp [Figure 1 and Table 1].
Since the alleles corresponding to bp size 200, between 200 and 252 bp, between 252 and 300 bp,
between 300 and 350 bp were very rare we considered them as minor alleles and grouped them under
two main classes of major alleles; 252 bp* (containing alleles of size up to 252 bp) and 300 bp*
(containing alleles corresponding to more than 252 bp).
260
260 280
2
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
3 of 13 1/27/2014 5:56 PM
The tandem repeat (300 bp*) allele frequency was found to be 1.35% in the controls and 8.108% in
cases. The tandem repeat (252 bp*) allele frequency was found to be 91.89% in cases and 98.65% in
controls. The 252 bp/252 bp genotype was found to be present in 89.18% of the cases and 98.64% of
the controls the 252 bp/300 bp variant in 5.40% of the cases and none among the controls and the
300 bp/300 bp genotype in 5.40% of cases and 1.35% of controls [Tables 2 and 3].
It was observed that although the proportion of individuals who were homozygous for the tandem
repeat (300 bp/300 bp) was higher in cases than in controls the difference was not statistically
significant when using 252 bp/252 bp genotype as a reference (OR=4.4242; 95% CI 0.4822-40.5924);
P=0.1529). However, it was observed that the frequency of the heterozygous genotype (252 bp/300
bp) when compared with 252 bp/252 bp showed statistical significance (OR=8.0603; 95% CI
1.1112-58.4646; P=0.0383).
General characteristics of the study population
Various general characteristics of the study population like mean age gender dwelling and socio-
economic status were analyzed between cases and controls, but no statistical significance was
observed [Table 4].
D18S452 genotypes and clinic pathological variables
Table 5 shows the genotype frequencies of D18S452 polymorphism relating to age gender dwelling
socio-economic status BPAD subtype family history and age at onset. No statistical significance was
attained.
DISCUSSION
Overall results suggests that there is a significant association between D18S452 maker with tandem
repeat polymorphism in heterozygous condition (252 bp/300 bp) and the development of BPAD in
Kashmiri population. The susceptible marker was not explored earlier and its analysis reveals
important information regarding the types and frequency of alleles. On the basis of the frequency in
the subject, the identified six alleles can be sorted into two categories – frequent and rare one. The
allele size determined by the number of dinucleotide (CA) ranged from 200 to 350 bp. The allele 252
bp was predominant in both cases and controls but the 252/300 bp allele was found only in cases
(5.40%) and importantly in none of the controls. Most of the alleles are more or less similar in the
cases and a significant association between tandem repeat polymorphism in heterozygous condition
(252 bp/300 bp) and the development of BPAD in Kashmiri population turns out. There can be many
possible ways by which the genotype can contribute to the development of BPAD. It can influence at
organizational level of chromosome, its accessibility to various factors and regulatory proteins.
Chromosomal locus 18p11.2 harbors many candidate genes like NAPG[28] GNAL[29] NDUFV2[24]
and VAPA.[30] It may be possible that this marker is directly or indirectly involved in the regulation
of neighboring genes. It is also possible that this locus may be in linkage disequilibrium with other
genes.
The result of our study further adds to the data from several other studies which have also shown an
association between chromosomal locus 18p and the risk of BPAD. In one study, chromosome 18p has
been shown to be a highly susceptible locus for the affective mood disorder[19] Further, support for
this region comes from evidence suggesting potential overlap with schizophrenia; Schwab et al.,
reported a possible schizophrenia locus on 18p11.2 and demonstrated that evidence for linkage in
these schizophrenia families increased when individuals with affective diagnoses were also included
in the analysis.[31] A susceptibility gene on chromosome 18 and a parent-of-origin effect have been
suggested for BPAD.[13] In studies of persons with chromosome 18p - deletions, there have been
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
4 of 13 1/27/2014 5:56 PM
reports of paranoid psychosis, depression and subclinical obsessive compulsive disorder.[32] In
studies of 18qsyndromes, there have also been individual reports of violent/aggressive behaviors.[33]
There is one report of a behavioral/psychiatric problem in a case of chromosome 18p tetrasomy; an
individual who had a history of aggressive, self-injurious and destructive behavior.[34] There is also a
report of a family with a pericentric inversion of chromosome 18, in which three individuals (two with
dup (18p)/del (18q) and one with dup (18q)/del (18p), all displayed depression and anxiety.[35]
We also tried to correlate many clinico-phenotypic conditions like BPAD subtype, age at on set and
other general characteristics with D18S452 polymorphism, but we could not find any significant
association [Table 5].
It may pave a way to understand the development of the BPAD. It can serve us a lead from where we
can further explore the biological significance of the identified genotypes and their association with
BPAD. The management and therapeutic targets may be identified by designing additional studies on
such findings. Bigger sample size, biological characterization of the genotypes in the susceptible and
sequencing of such repetitive DNA sequences by modern sequencing technology seems inevitable for
further substantiation of our findings.
CONCLUSION
Overall our study suggests that there is a significant association between tandem repeat
polymorphism in heterozygous condition (252 bp/300 bp) and the development of BPAD in Kashmiri
population. We identified the alleles of the marker D18S452 most of which are a frequent. There are
various possible ways by which the 252/300 bp genotype can influence the development of the BPAD.
Further studies are required for better understanding of the roles of the genotypes in BAPD
pathophysiology.
Footnotes
Source of Support: Nil
Conflict of Interest: None declared.
REFERENCES
1. Goodwin FK, Jamison KR. New York: Oxford University Press; 1990. Manic Depressive Illness.
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and
age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch
Gen Psychiatry. 2005;62:593–602. [PubMed: 15939837]
3. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ, et al. Distribution of major
health risks: Findings from the global burden of disease study. PLoS Med. 2004;1:E27.
[PMCID: PMC523844] [PubMed: 15526049]
4. Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W, et al. A family study of
schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry.
1982;39:1157–67. [PubMed: 7125846]
5. Bertelsen A, Harvald B, Hauge M. A Danish twin study of manic-depressive disorders. Br J
Psychiatry. 1977;130:330–51. [PubMed: 558030]
6. Mendlewicz J, Rainer JD. Adoption study supporting genetic transmission in manic – Depressive
illness. Nature. 1977;268:327–9. [PubMed: 887159]
7. Risch N, Botstein D. A manic depressive history. Nat Genet. 1996;12:351–3. [PubMed: 8630482]
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
5 of 13 1/27/2014 5:56 PM
8. Berrettini WH. Genetics of psychiatric disease. Annu Rev Med. 2000;51:465–79.
[PubMed: 10774477]
9. Bennett P, Segurado R, Jones I, Bort S, McCandless F, Lambert D, et al. The wellcome trust
UK-Irish bipolar affective disorder sibling-pair genome screen: First stage report. Mol Psychiatry.
2002;7:189–200. [PubMed: 11840312]
10. Craddock N, Owen M, Burge S, Kurian B, Thomas P, McGuffin P. Familial cosegregation of major
affective disorder and Darier's disease (keratosis follicularis) Br J Psychiatry. 1994;164:355–8.
[PubMed: 8199789]
11. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI, Jr, et al.
Chromosome 18 DNA markers and manic-depressive illness: Evidence for a susceptibility gene. Proc
Natl Acad Sci U S A. 1994;91:5918–21. [PMCID: PMC44108] [PubMed: 8016089]
12. Straub RE, Lehner T, Luo Y, Loth JE, Shao W, Sharpe L, et al. A possible vulnerability locus for
bipolar affective disorder on chromosome 21q22.3. Nat Genet. 1994;8:291–6. [PubMed: 7874172]
13. Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C, et al. Evidence for linkage of
bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet. 1995;57:1384–94.
[PMCID: PMC1801428] [PubMed: 8533768]
14. Blackwood DH, He L, Morris SW, McLean A, Whitton C, Thomson M, et al. A locus for bipolar
affective disorder on chromosome 4p. Nat Genet. 1996;12:427–30. [PubMed: 8630499]
15. Adams LJ, Mitchell PB, Fielder SL, Rosso A, Donald JA, Schofield PR. A susceptibility locus for
bipolar affective disorder on chromosome 4q35. Am J Hum Genet. 1998;62:1084–91.
[PMCID: PMC1377083] [PubMed: 9545396]
16. Craddock N, Jones I. Genetics of bipolar disorder. J Med Genet. 1999;36:585–94.
[PMCID: PMC1762980] [PubMed: 10465107]
17. Friddle C, Koskela R, Ranade K, Hebert J, Cargill M, Clark CD, et al. Full-genome scan for linkage
in 50 families segregating the bipolar affective disease phenotype. Am J Hum Genet.
2000;66:205–15. [PMCID: PMC1288327] [PubMed: 10631152]
18. Badenhop RF, Moses MJ, Scimone A, Mitchell PB, Ewen-White KR, Rosso A, et al. A genome
screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on
chromosome 3 as well as chromosomes 9, 13 and 19. Mol Psychiatry. 2002;7:851–9.
[PubMed: 12232778]
19. Ginns EI, St Jean P, Philibert RA, Galdzicka M, Damschroder-Williams P, Thiel B, et al. A
genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk
for bipolar affective disorder among the old order Amish. Proc Natl Acad Sci U S A. 1998;95:15531–6.
[PMCID: PMC28077] [PubMed: 9861003]
20. Bassett AS. Chromosomal aberrations and schizophrenia. Autosomes. Br J Psychiatry.
1992;161:323–34. [PMCID: PMC3188307] [PubMed: 1393302]
21. McInnes LA, Escamilla MA, Service SK, Reus VI, Leon P, Silva S, et al. A complete genome screen
for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci U S
A. 1996;93:13060–5. [PMCID: PMC24046] [PubMed: 8917544]
22. Mukherjee O, Meera P, Ghosh S, Kubendran S, Kiran K, Manjunath KR, et al. Evidence of linkage
and association on 18p11.2 for psychosis. Am J Med Genet B Neuropsychiatr Genet.
2006;141B:868–73. [PubMed: 16941653]
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
6 of 13 1/27/2014 5:56 PM
23. Chavarría-Siles I, Walss-Bass C, Quezada P, Dassori A, Contreras S, Medina R, et al.
TGFB-induced factor (TGIF): A candidate gene for psychosis on chromosome 18p. Mol Psychiatry.
2007;12:1033–41. [PubMed: 17440433]
24. Washizuka S, Iwamoto K, Kakiuchi C, Bundo M, Kato T. Expression of mitochondrial complex I
subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and
schizophrenia. Neurosci Res. 2009;63:199–204. [PubMed: 19135101]
25. Li X, Zhang J, Wang Y, Ji J, Yang F, Wan C, et al. Association study on the NAPG gene and
bipolar disorder in the Chinese Han population. Neurosci Lett. 2009;457:159–62.
[PubMed: 19429185]
26. Washizuka S, Iwamoto K, Kazuno AA, Kakiuchi C, Mori K, Kametani M, et al. Association of
mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the
National Institute of Mental Health Pedigrees. Biol Psychiatry. 2004;56:483–9. [PubMed: 15450783]
27. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from
eukaryotes. Nucleic Acids Res. 1976;3:2303–8. [PMCID: PMC343085] [PubMed: 987581]
28. Weller AE, Dahl JP, Lohoff FW, Ferraro TN, Berrettini WH. Analysis of variations in the NAPG
gene on chromosome 18p11 in bipolar disorder. Psychiatr Genet. 2006;16:3–8. [PubMed: 16395123]
29. Tsiouris SJ, Breschel TS, Xu J, McInnis MG, McMahon FJ. Linkage disequilibrium analysis of
G-olf alpha (GNAL) in bipolar affective disorder. Am J Med Genet. 1996;67:491–4.
[PubMed: 8886169]
30. Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Berrettini WH. Association between
polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on
chromosome 18p and bipolar disorder. J Neural Transm. 2008;115:1339–45. [PubMed: 18665321]
31. Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Hönig S, et al. Support for a
chromosome 18p locus conferring susceptibility to functional psychoses in families with
schizophrenia, by association and linkage analysis. Am J Hum Genet. 1998;63:1139–52.
[PMCID: PMC1377479] [PubMed: 9758604]
32. Babovic-Vuksanovic D, Jenkins SC, Ensenauer R, Newman DC, Jalal SM. Subtelomeric deletion of
18p in an adult with paranoid schizophrenia and mental retardation. Am J Med Genet A.
2004;124A:318–22. [PubMed: 14708108]
33. Mahr RN, Moberg PJ, Overhauser J, Strathdee G, Kamholz J, Loevner LA, et al. Neuropsychiatry
of 18q- syndrome. Am J Med Genet. 1996;67:172–8. [PubMed: 8723044]
34. Swingle HM, Ringdahl J, Mraz R, Patil S, Keppler-Noreuil K. Behavioral management of a
long-term survivor with tetrasomy 18p. Am J Med Genet A. 2006;140:276–80. [PubMed: 16411237]
35. Vermeulen SJ, Speleman F, Vanransbeeck L, Verspeet J, Menten B, Verschraegen-Spae MR, et al.
Familial pericentric inversion of chromosome 18: Behavioral abnormalities in patients heterozygous
for either the dup (18p)/del (18q) or dup (18q)/del (18p) recombinant chromosome. Eur J Hum
Genet. 2005;13:52–8. [PubMed: 15470365]
Figures and Tables
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
7 of 13 1/27/2014 5:56 PM
Figure 1
Representative gel picture showing 3% agarose gel electrophoresis after polymerase chain reaction lane 1 represents
negative control; lane 2 and 4 represents homozygous condition (300 bp); lane 3 represents homozygous condition
(252-300 bp) lane 5 represents homozygous condition (200 bp); lane 6 represents heterozygous condition (252
bp/300-350 bp); lane 7-10, 12 and 14 represents homozygous condition (252 bp); lane 13 represents homozygous
condition (200-252 bp). Lane 11 represents 50 bp ladders
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
8 of 13 1/27/2014 5:56 PM
Table 1
Frequency of D18S452 alleles (major and minor alleles) in the study population
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
9 of 13 1/27/2014 5:56 PM
Table 2
Frequency of D18S452 alleles (after grouping) in the study population
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
10 of 13 1/27/2014 5:56 PM
Table 3
Genotypic frequencies of D18S452 polymorphism in the study population
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
11 of 13 1/27/2014 5:56 PM
Table 4
General characteristics of the study population
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
12 of 13 1/27/2014 5:56 PM
Table 5
Correlation between D18S452 polymorphism and clinico-pathological characteristics
Articles from Indian Journal of Psychiatry are provided here courtesy of Medknow Publications
Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar... http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890926/?report=printable
13 of 13 1/27/2014 5:56 PM